Article Access statistics

Viewed: 161

Emailed: 0

PDF Downloaded: 136

IP Indian Journal of Clinical and Experimental Dermatology


Clinico demographic evaluation of vitiligo and associated autommune disorders: A prospective study in up region


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Vijay Prakash Gupta*

Volume : 6, Issue : 2, Year : 2020

Article Page : 163-167


Suggest article by email

Abstract

Introduction : This study was carried out with an objective to document clinico-epidemiological features
of vitiligo from this part of the country having varied geo-climatic conditions, rural and semi-urban
communities of diverse ethnic backgrounds.
Materials and Methods : The diagnosis of vitiligo was essentially clinical, confirmed by at least three
senior dermatologists. Clinically ambiguous cases and lesions not accentuating under Woods’ light were
excluded. The vitiligo patients were classified according to recent Bordeaux vitiligo global issues consensus
conference classification and consensus nomenclatureinto three groups, viz. non-segmental, segmental, and
unclassified vitligo.
Result : There were 390 men and 460 women (m:f 1:1.1) aged between 2 and 80 years (mean 23.5 years)
at presentation. The patients were distributed across all age groups and the majority 450 (52.9%) patients
were aged 20 years and also comprised 230 (27.5%) children aged up to 12 years.
Conclusion : The patients with an affected first-degree family member may have more chances of onset at
an early age compared with others but without a significant difference.

Keywords: Vitiligo, Autommune Disorders, Dermatology.


Doi : 10.18231/j.ijced.2020.032

How to cite : Gupta V P, Clinico demographic evaluation of vitiligo and associated autommune disorders: A prospective study in up region. IP Indian J Clin Exp Dermatol 2020;6(2):163-167

Copyright © 2020 by author(s) and IP Indian J Clin Exp Dermatol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)